老年仅活检胶质母细胞瘤患者不良预后相关因素
该回顾性研究纳入2017至2020年132例年龄>65岁、仅接受活检的胶质母细胞瘤患者,分析术前因素与三个月生存及治疗完成情况的关系。中位总生存期为4.6个月,50%完成治疗;术前体能状态差、肿瘤体积大和肿瘤位于中央与三个月生存降低独立相关,体能状态差是治疗未完成的唯一预测因素。
要点
- 术前体能状态差、肿瘤体积大、中央位置与老年活检GBM患者短期生存降低独立相关。
- 术前体能状态差是治疗未完成的唯一预测因素,该亚组中位OS仅1.6个月。
- 这些因素可用于向脆弱患者群体咨询活检的潜在获益。
核心结论
- 在老年仅活检胶质母细胞瘤患者中,术前体能状态差、中央肿瘤位置和较大肿瘤体积与短期生存降低显著相关。
- 术前体能状态差的患者完成治疗的可能性更低。
研究设计与样本
- 回顾性研究,纳入2017至2020年年龄>65岁的仅活检胶质母细胞瘤患者132例。
- 采用逻辑回归分析术前预后因素,Kaplan-Meier法估计总生存期。
主要发现
- 中位总生存期为4.6个月,50%的患者完成治疗。
- 17%的患者接受姑息治疗,其中位总生存期为1.3个月。
- 体能状态差(OR=0.2)、较大肿瘤体积(OR=0.9)和中央肿瘤位置(OR=0.3)与三个月生存降低独立相关。
- 体能状态差是治疗未完成的唯一预测因素(OR=0.06);该亚组中位总生存期为1.6个月,21例中仅1例完成治疗。
临床怎么用
- 对于老年仅活检胶质母细胞瘤患者,术前评估体能状态、肿瘤体积和位置有助于预测短期生存和治疗完成可能性。
- 术前体能状态差的患者治疗完成率低、生存期短,可用于医患沟通活检的潜在获益。
局限性
- 回顾性研究设计。
- 仅纳入年龄>65岁且仅接受活检的患者,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Glioblastoma (GBM) in elderly patients has a poor prognosis. About one-third of patients have impaired perioperative performance status (PS) and often excluded from clinical trials. Brain biopsy is the standard diagnostic approach when resection is not feasible. Previous studies on preoperative prognostic factors have mostly focused on resected patients. This study aimed to identify preoperative factors associated with reduced three-month survival and treatment incompletion in elderly biopsy-only patients, with the three-month endpoint reflecting early mortality and rapid disease progression that often prevents treatment completion. METHODS: We retrospectively reviewed biopsy-only GBM patients aged > 65 years between 2017 and 2020. Preoperative prognostic factors were analyzed using logistic regression, and overall survival (OS) was estimated using Kaplan-Meier. RESULTS: A total of 132 patients were included. Median OS was 4.6 months, and 50% completed treatment. Palliative treatment was given to 17% of patients (median OS 1.3 months). Poor PS (OR = 0.2), larger tumor volume (OR = 0.9), and central tumor location (OR = 0.3) were independently associated with reduced three-month survival. Poor PS was the only predictor of treatment incompletion (OR = 0.06); in this subgroup, The median OS was 1.6 months, with only one of 21 completing treatment. CONCLUSION: In elderly patients with biopsy-only GBM, poor preoperative PS, central tumor location, and larger tumor volume were significantly associated with reduced short-term survival. Patients with poor preoperative PS were also less likely to complete treatment. These findings may aid in counseling on the potential benefits of biopsy in this vulnerable group.
引用
- Edriss J, Cheung J, Kronvall E, et al. Factors associated with poor prognosis in elderly biopsy-only glioblastoma patients. Acta Neurochir (Wien). 2025. PMID: 41073811. doi:10.1007/s00701-025-06681-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。